Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smaller UPC codes on OTC labels would be costly and inefficient -- UCC tells FDA.

This article was originally published in The Tan Sheet

Executive Summary

SMALLER UPC SYMBOLS WOULD REQUIRE COSTLY OTC RELABELING, the Uniform Code Council asserted in an Oct. 30 letter to FDA. "There are millions of OTC drug labels today containing UPC symbols within [UCC] specifications," the council pointed out, adding: "If FDA were to mandate a smaller symbol, not only would it make product scanning much more difficult, if not impossible, it would require product manufacturers to relabel at an enormous cost."





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts